×
Breaking News
WORLD PATIENT SAFETY DAY 2026 | Safe Care for Life
WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA | FDA Approves First Disease-Specific Treatment
NEW BOOK | Unseen Battle with Thalassemia by Raj Choudhary
THE MENA THALASSAEMIA EXPERIENCE | 30–31 October 2026
INTERNATIONAL THALASSAEMIA DAY 2026 | Global Activities Report Now Available
GLOBAL HEMATOLOGY | TIF Publishes EHA 2026 Key Takeaways
RARE ANAEMIAS | RAIN Publishes EHA 2026 Research Highlights
TIF WEBINAR SERIES 2026 | Bridging the Communication Gap in Haemoglobinopathy Care
WORLD BLOOD DONOR DAY 2026 | One Drop of Humanity. Give Blood. Save Lives.
EU APPROVES MITAPIVAT | A New Treatment Milestone for Adults with α- or β-Thalassaemia
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Other Anaemias
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Home
/
Catherine Skari
Catherine Skari
Aug
- 2023 -
21 August
Oral Ferroportin Inhibitor
Read More »
21 August
CASGEVY™ (gene editing)
Read More »
21 August
Etavopivat
Read More »
21 August
PYRUKYND®
Read More »
21 August
Adakveo®
Read More »
21 August
Oxbryta®
Read More »
21 August
INTERCEPT™(pathogen inactivation)
Read More »
20 August
Hemanext ONE®
Read More »
20 August
Ferriprox®
Read More »
20 August
Reblozyl®
Read More »
Previous page
Next page
Back to top button
Close
Search for
